Megacv%2525252525252525252525252520duo

# Megacv Duo (Amoxicillin/Clavulanate Potassium) ## Overview Megacv Duo refers to a fixed-dose combination antibiotic containing Amoxicillin (a beta-lactam penicillin) and Clavulanate Potassium (a beta-lactamase inhibitor). The combination extends the spectrum of activity to include beta-lactamase-producing organisms. ## Primary Indications - Community-acquired pneumonia - Acute bacterial rhinosinusitis - Acute otitis media - Skin and skin structure infections - Urinary tract infections - Dental infections ## Adult Dosing Standard dosing is based on the amoxicillin component. - **Mild to Moderate Infections:** 500 mg amoxicillin/125 mg clavulanate every 8 hours OR 875 mg amoxicillin/125 mg clavulanate every 12 hours. - **Severe Infections/Respiratory Tract Infections:** 875 mg amoxicillin/125 mg clavulanate every 8 to 12 hours. - **Maximum Daily Dose:** Do not exceed 2000 mg/day of amoxicillin (based on conventional 875 mg formulations) unless specific high-dose protocols for resistant *S. pneumoniae* are utilized. ## Pediatric Dosing - **Standard Dosing:** 20–45 mg/kg/day (based on amoxicillin component) divided every 8–12 hours depending on the severity of infection. - **Acute Otitis Media/Recurrent Infections:** Often 80–90 mg/kg/day (amoxicillin component) divided every 12 hours using 7:1 or 14:1 ratio formulations to minimize clavulanate-associated diarrhea. - **Note:** Always verify the specific concentration/ratio provided by the manufacturer in your region as oral suspensions vary significantly. ## Dose Adjustments - **Renal Impairment (CrCl < 30 mL/min):** Avoid extended-release formulations. Dose reduction or interval extension is required. Do not use the 875 mg tablet in patients with severe renal impairment (CrCl < 30 mL/min). - **Hepatic Impairment:** Use with caution; monitor hepatic function periodically. ## Contraindications - Known hypersensitivity to any penicillin or clavulanate. - History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate. - Severe renal impairment (CrCl < 30 mL/min) for specific high-dose formulations (e.g., 875 mg). ## Adverse Effects - **Common:** Diarrhea (frequently associated with the clavulanate component), nausea, vomiting, skin rash, and oral candidiasis. - **Serious:** Clostridioides difficile-associated diarrhea (CDAD), hepatotoxicity (often cholestatic), severe hypersensitivity reactions (anaphylaxis), and drug-induced seizures (rare, primarily in renal failure). ## Key Drug Interactions - **Warfarin:** May increase INR and risk of bleeding; monitor PT/INR when starting or stopping therapy. - **Methotrexate:** Penicillins may decrease renal clearance, increasing risk of toxicity. - **Probenecid:** Decreases renal tubular secretion of amoxicillin, resulting in increased and prolonged blood levels of amoxicillin. - **Oral Contraceptives:** May reduce efficacy; efficacy is debated, but barrier contraception is recommended during therapy. ## Monitoring - Periodic assessment of renal and hepatic function (AST/ALT/Bilirubin) during prolonged therapy. - Monitor for signs/symptoms of hypersensitivity (rash, urticaria, wheezing). - Monitor for persistent diarrhea (symptom of pseudomembranous colitis). ## Clinical Pearls - **Administration:** Administer at the start of a meal to minimize gastrointestinal upset and ensure optimal absorption. - **Ratios:** The amount of clavulanate must be limited to prevent severe diarrhea. Ensure the correct ratio is selected for the specific infection to avoid exceeding the daily limit of clavulanate. - **Resistance:** Amoxicillin/clavulanate remains a primary choice for beta-lactamase producing *H. influenzae* and *M. catarrhalis*. *** **Educational Disclaimer:** This information is for educational purposes only. Drug dosing, indications, and safety information can change based on local hospital protocols, antibiotic stewardship guidelines, and updated manufacturer labeling. Always verify the current prescribing information via local clinical decision support systems or the official product monograph before prescribing or administering medication.